nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR5—midbrain—Gilles de la Tourette syndrome	0.0527	0.0908	CbGeAlD
Fingolimod—S1PR5—nervous system—Gilles de la Tourette syndrome	0.0434	0.0746	CbGeAlD
Fingolimod—S1PR5—central nervous system—Gilles de la Tourette syndrome	0.0417	0.0719	CbGeAlD
Fingolimod—S1PR1—midbrain—Gilles de la Tourette syndrome	0.0386	0.0665	CbGeAlD
Fingolimod—SPHK1—midbrain—Gilles de la Tourette syndrome	0.0382	0.0658	CbGeAlD
Fingolimod—CYP4F12—midbrain—Gilles de la Tourette syndrome	0.0367	0.0632	CbGeAlD
Fingolimod—S1PR3—nervous system—Gilles de la Tourette syndrome	0.036	0.062	CbGeAlD
Fingolimod—S1PR3—central nervous system—Gilles de la Tourette syndrome	0.0347	0.0597	CbGeAlD
Fingolimod—S1PR5—brain—Gilles de la Tourette syndrome	0.0331	0.0571	CbGeAlD
Fingolimod—S1PR1—nervous system—Gilles de la Tourette syndrome	0.0318	0.0547	CbGeAlD
Fingolimod—SPHK1—nervous system—Gilles de la Tourette syndrome	0.0314	0.0541	CbGeAlD
Fingolimod—S1PR1—central nervous system—Gilles de la Tourette syndrome	0.0306	0.0526	CbGeAlD
Fingolimod—S1PR3—brain—Gilles de la Tourette syndrome	0.0275	0.0474	CbGeAlD
Fingolimod—S1PR1—brain—Gilles de la Tourette syndrome	0.0243	0.0418	CbGeAlD
Fingolimod—SPHK1—brain—Gilles de la Tourette syndrome	0.024	0.0414	CbGeAlD
Fingolimod—CYP4F12—brain—Gilles de la Tourette syndrome	0.0231	0.0397	CbGeAlD
Fingolimod—S1PR1—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0164	0.039	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0159	0.0379	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0104	0.0247	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00876	0.0209	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0085	0.0203	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00843	0.0201	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00843	0.0201	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00819	0.0195	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00819	0.0195	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00792	0.0189	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00766	0.0183	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00763	0.0182	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00763	0.0182	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00743	0.0177	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00696	0.0166	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00692	0.0165	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00676	0.0161	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0067	0.016	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0067	0.016	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00651	0.0155	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00651	0.0155	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0063	0.015	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00609	0.0145	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00606	0.0145	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00606	0.0145	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00591	0.0141	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00551	0.0131	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—HDC—Gilles de la Tourette syndrome	0.0053	0.0127	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0053	0.0127	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00515	0.0123	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00511	0.0122	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00511	0.0122	CbGpPWpGaD
Fingolimod—CYP2E1—nervous system—Gilles de la Tourette syndrome	0.00509	0.00877	CbGeAlD
Fingolimod—S1PR3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00496	0.0118	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00496	0.0118	CbGpPWpGaD
Fingolimod—CYP2E1—central nervous system—Gilles de la Tourette syndrome	0.0049	0.00844	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0048	0.0114	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00464	0.0111	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00462	0.011	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00462	0.011	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—HDC—Gilles de la Tourette syndrome	0.00458	0.0109	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0045	0.0107	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00441	0.0105	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00425	0.0101	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00425	0.0101	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00419	0.01	CbGpPWpGaD
Fingolimod—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.0041	0.00705	CbGeAlD
Fingolimod—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00403	0.00694	CbGeAlD
Fingolimod—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.00395	0.00679	CbGeAlD
Fingolimod—SPHK1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00393	0.00939	CbGpPWpGaD
Fingolimod—CYP2E1—brain—Gilles de la Tourette syndrome	0.00389	0.0067	CbGeAlD
Fingolimod—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00388	0.00668	CbGeAlD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00386	0.0092	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00336	0.00802	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00323	0.00772	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00323	0.00772	CbGpPWpGaD
Fingolimod—CYP2D6—brain—Gilles de la Tourette syndrome	0.00308	0.00531	CbGeAlD
Fingolimod—S1PR4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.003	0.00715	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00294	0.00701	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00291	0.00694	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00288	0.00688	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00288	0.00688	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0028	0.00668	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0028	0.00668	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00272	0.00649	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00271	0.00647	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00264	0.00631	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00262	0.00625	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00262	0.00625	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00262	0.00625	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00261	0.00623	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00261	0.00623	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00254	0.00607	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00254	0.00607	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00254	0.00607	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00246	0.00587	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00238	0.00568	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00237	0.00565	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00237	0.00565	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00237	0.00565	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00231	0.00551	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00215	0.00513	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0019	0.00453	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00183	0.00436	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00183	0.00436	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00172	0.00411	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00396	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00396	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00166	0.00396	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00161	0.00384	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00156	0.00372	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00155	0.00369	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00155	0.00369	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00151	0.0036	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0015	0.00359	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0015	0.00359	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00145	0.00347	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00141	0.00335	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0014	0.00334	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.0014	0.00334	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00136	0.00326	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00127	0.00303	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00124	0.00297	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00121	0.00288	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00112	0.00268	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00243	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00098	0.00234	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00098	0.00234	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00089	0.00212	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000788	0.00188	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000646	0.00154	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000458	0.00109	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.0003	0.000715	CbGpPWpGaD
